More related to diabetes, a study from 201229 found that metformin, an antidiabetic drug previously shown to have antitumor activity in several different cancers,30 did not affect BRAF‐mutated melanoma cells, but instead seemed to accelerate their growth in a xenograft mice model of melanoma. This evidence concerns the gene BRAF and diabetes mellitus.